ORUC ALLAHVERDİYEV, ASLI ZENGİN TÜRKMEN, ASİYE NURTEN, İCLAL ŞEHİRLİ, NURHAN ENGİNAR

Spontaneous withdrawal in intermittent morphine administration in rats and mice: effect of clonidine coadministration and sex-related differences

Background/aim: Treating animals repeatedly with intermittent and increasing morphine doses has been suggested to allow some withdrawal during each dosing interval, which causes repeated stress. The present study aimed to test this hypothesis and assess sex-related differences in withdrawal signs and their suppression by clonidine. Materials and methods: Male and female rats and mice were administered with increasing doses of morphine twice daily at different dosing intervals. Rats were given clonidine in drinking water (5 μg/mL). Spontaneous and naloxone-precipitated withdrawal signs and novelty-induced grooming were evaluated. Results: Male rats and male and female rats displayed manifestations of morphine withdrawal at the end of 14-h and 24-h dosing intervals, respectively. Clonidine attenuated the severity of the withdrawal signs. Male but not female mice displayed withdrawal signs at the end of 12-h and 17-h dosing intervals. Female mice exhibited less pronounced naloxone-precipitated withdrawal syndrome. Grooming did not reflect a "stress-like state" in morphine-treated animals. Conclusion: These findings indicate intermittent morphine treatment-induced spontaneous withdrawal in rats and mice and sex-related differences in spontaneous and naloxone-precipitated withdrawal signs in mice. Since the treatment protocol closely parallels the drug use pattern in opioid addicts, further experiments are needed to clarify the stress associated with the treatment and the efficacy of sedatives.

Anahtar Kelimeler:

Morphine, intermittent treatment, clonidine, spontaneous withdrawal, grooming, sex, dependence

Spontaneous withdrawal in intermittent morphine administration in rats and mice: effect of clonidine coadministration and sex-related differences

Keywords:

Morphine, intermittent treatment, clonidine, spontaneous withdrawal, grooming, sex, dependence,

PDF

___

Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 2001; 81: 299–343.
Schulteis G, Koob GF. Reinforcement processes in opiate addiction: a homeostatic model. Neurochem Res 1996; 21: 1437–1454.
Gowing L, Farrell M, Ali R, White JM. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Db Syst Rev 2009; 3: CD002024.
Craft RM, Stratmann JA, Bartok RE, Walpole TI, King SJ. Sex differences in development of morphine tolerance and dependence in the rat. Psychopharmacology 1999; 143: 1–7.
Diaz SL, Kemmling AK, Rubio MC, Balerio GN. Lack of sex-related differences in the prevention by baclofen of the morphine withdrawal syndrome in mice. Behav Pharmacol 2001; 12: 75–79.
Kest B, Palmese CA, Hopkins E, Adler M, Juni A. Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol Biochem Behav 2001; 70: 149–156.
Cicero TJ, Nock B, Meyer ER. Gender-linked differences in the expression of physical dependence in the rat. Pharmacol Biochem Behav 2002; 72: 691–697.
Papaleo F, Contarino A. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice. Behav Brain Res 2006; 170: 110–118.
Langerman L, Piscoun B, Bansinath M, Shemesh Y, Turndorf H, Grant GJ. Quantifiable dose-dependent withdrawal after morphine discontinuation in a rat model. Pharmacol Biochem Behav 2001; 68: 1–6.
Lenard NR, Roerig SC. Development of antinociceptive tolerance and physical dependence following morphine i.c.v. infusion in mice. Eur J Pharmacol 2005; 527: 71–76.
Blum K, Eubanks JD, Wiggins B, Wallace JE. Morphine withdrawal reactions in male and female mice. Am J Drug Alcohol Ab 1976; 3: 363–368.
Koyuncuoglu H, Nurten A, Yamantürk P, Nurten R. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine. Pharmacol Res 1999; 39: 311–319.
Zhou H, Ge X, Wang LZ, Ma L, Pei G. Attenuation of morphine tolerance and dependence in scopolamine-treated rats. Neuroreport 1999; 10: 2007–2010.
Li T, Hou Y, Cao W, Yan CX, Chen T, Li SB. Naloxone- precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice. Neurosci Lett 2010; 468: 348–352.
Cobuzzi JL, Riley AL. Spontaneous withdrawal in opiate- dependent Fischer 344, Lewis and Sprague–Dawley rats. Pharmacol Biochem Behav 2011; 98: 28–43.
Rehni AK, Singh N, Rachamalla M, Tikoo K. Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome. N-S Arch Pharmacol 2012; 385: 605– 619.
Houshyar H, Galigniana MD, Pratt WB, Woods JH. Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative feedback and corticotropin-releasing hormone in rats undergoing acute and chronic morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. J Neuroendocrinol 2001; 13: 875– 886.
Houshyar H, Gomez F, Manalo S, Bhargava A, Dallman MF. Intermittent morphine administration induces dependence and is a chronic stressor in rats. Neuropsychopharmacology 2003; 28: 1960–1972.
Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depen 1998; 51: 23– 47.
Shalev U, Morales M, Hope B, Yap J, Shaham Y. Time- dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology 2001; 156: 98–107.
Raz S, Berger BD. Social isolation increases morphine intake: behavioral and psychopharmacological aspects. Behav Pharmacol 2010; 21: 39–46.
Meyer DR, El-Azhary R, Bierer DWS, Hanson SK, Robbins MS, Sparber SB. Tolerance and dependence after chronic administration of clonidine to the rat. Pharmacol Biochem Behav 1997; 7: 227–231.
Abdel-Rahman AA. Alcohol abolishes the hypotensive effect of clonidine in spontaneously hypertensive rats. Hypertension 1994; 24: 802–807.
Enginar N, Koyuncuoğlu H, Hatipoğlu İ, Dişçi R, Eroğlu L. Chronic clonidine administration-induced behavioral hyperactivity: effects of imipramine, propranolol and diazepam. Med Bull Istanbul 1996; 29: 77–81.
Caillé S, Espejo EF, Reneric JP, Cador M, Koob GF, Stinus L. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther 1999; 290: 881–892.
Streel E, Dan B, Campanella S, Meyvaert A, Hanak C, Pelc I, Verbanck P. A pharmacological modulation of opiate withdrawal using an up-/down-regulation of the noradrenergic system in opiate-dependent rats. Int J Neuropsychoph 2006; 9: 621–626.
Marroni SS, Nakano FN, Gati CDC, Oliveira JAC, Antunes- Rodrigues J, Garcia-Cairasco N. Neuroanatomical and cellular substrates of hypergrooming induced by microinjection of oxytocin in central nucleus of amygdala, an experimental model of compulsive behavior. Mol Psychiatr 2007; 12: 1103– 1117.
Ruiz F, Fournié-Zaluski MC, Roques BP, Maldonado R. Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism. Brit J Pharmacol 1996; 119: 174–182.
Deneau GA, Seevers MH. Pharmacological aspects of drug dependence. Adv Pharmacol 1964; 3: 267–283.
Papaleo F, Ghozland S, Ingallinesi M, Roberts AJ, Koob GF, Contarino A. Disruption of the CRF2 receptor pathway decreases the somatic expression of opiate withdrawal. Neuropsychopharmacology 2008; 33: 2878–2887.
Palucha-Poniewiera A, Novak K, Pilc A. Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 1454–1457.
Hu Z, Deng Y, Hu C, Deng P, Bu Q, Yan G, Zhou J, Shao X, Zhao J, Li Y et al. 1H NMR-based metabonomic analysis of brain in rats of morphine dependence and withdrawal intervention. Behav Brain Res 2012; 231: 11–19.
Trujillo KA. Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence. Neuropsychopharmacology 1995; 13: 301–307.
Zhou Y, Bendor J, Hofmann L, Randesi M, Ho A, Kreek MJ. Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J Endocrinol 2006; 191: 137–145.
Sadeghi M, Sianati S, Anaraki DK, Ghasemi M, Paydar MJ, Sharif B, Mehr SE, Dehpour AR. Study of morphine-induced dependence in gonadectomized male and female mice. Pharmacol Biochem Behav 2009; 91: 604–609.
Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 1997; 21: 91–104.
El-Kadi AO, Sharif SI. The influence of chronic treatment with clonidine, yohimbine and idazoxan on morphine withdrawal. Psychopharmacology 1997; 132: 67–73.
Feily A, Abbasi N. The inhibitory effect of Hypericum perforatum extract on morphine withdrawal syndrome in rat and comparison with clonidine. Phytother Res 2009; 23: 1549– 1552.
Pinelli A, Trivulzio S. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine. J Pharmacol Toxicol 1997; 38: 117–131.
Ferrari AC, Camargo LA, Saad WA, Renzi A, de Luca LA, Menani JV. Clonidine and phenylephrine injected into the lateral hypothalamus inhibits water intake in rats. Brain Res 1990; 522: 125–130.
Leggio GM, Micale V, Le Foll B, Mazzola C, Nobrega JN, Drago F. Dopamine receptor D3 knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam. Eur Neuropsychopharmacol 2011; 21: 325–332.
Rodriguez Echandia EL, Broitman ST, Foscolo MR. Effect of serotonergic and catecholaminergic antagonists on mild- stress-induced excessive grooming in the rat. Behav Neurosci 1983; 97: 1022–1024.
Kalueff AV, Tuohimaa P. The grooming analysis algorithm discriminates between different levels of anxiety in rats: potential utility for neurobehavioural stress research. J Neurosci Meth 2005; 143: 169–177.
Fukushiro DF, Frussa-Filho R. Chronic amphetamine transforms the emotional significance of a novel but not a familiar environment: implications for addiction. Int J Neuropsychopharmacol 2011; 14: 955–965.
Kazakov VN, Panova TI, Panova LE. Stress in morphine- addicted rats: antistressor properties of comenic acid. Neurophysiology 2003; 35: 392–397.
Goeldner C, Lutz PE, Darcq E, Halter T, Clesse D, Ouagazzal AM, Kieffer BL. Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biol Psychiat 2011; 69: 236–244.
Taraschenko OD, Rubbinaccio HY, Shulan JM, Glick SD, Maisonneuve IM. Morphine-induced changes in acetylcholine release in the interpeduncular nucleus and relationship to changes in motor behavior in rats. Neuropharmacology 2007; 53: 18–26.
Yamazato M, Sakima A, Nakazato J, Seseko S, Muratani H, Fukiyama K. Hypotensive and sedative effects of clonidine injected into the rostral ventrolateral medulla of the conscious rats. Am J Physiol-Reg I 2001; 281: R1868–1876.
Kalueff AV, Tuohimaa P. Experimental modeling of anxiety and depression. Acta Neurobiol Exp 2004; 64: 439–448.
Komorowska J, Pellis SM. Regulatory mechanisms underlying novelty-induced grooming in the laboratory rat. Behav Process 2004; 67: 287–293.
Rodgers RJ. Animal models of ‘anxiety’: where next? Behav Pharmacol 1997; 8: 477–496.